Actively Recruiting
The Course of Acute Respiratory Failure in Geriatric Patients With Hip Fracture Using Different Modes of a Vibroacoustic Device for the Lungs
Led by Astana Medical University · Updated on 2026-04-08
60
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
This clinical trial investigates the course of acute respiratory failure in elderly patients with hip fractures by comparing different modes of a vibroacoustic device designed for the lungs. The study evaluates the use of the Vibrolung device, which produces a powerful vibroacoustic signal to treat and prevent respiratory complications, aiming to assess its effects on patients aged 60 to 85 who have respiratory failure and hip fractures. Participants will receive vibroacoustic pulmonary therapy using the Vibrolung device in one of two modes: "Pneumonia" or "Prevention." Treatment sessions will occur 4 to 6 times daily, each lasting about 5 minutes, over a 5-day period. The device's emitters are applied to affected lung areas, and the therapy is conducted by trained medical professionals, allowing for easy patient positioning without the need for active participation, which is particularly important for patients on ventilators or with limited mobility. During the study, arterial blood gases will be measured on the first day to assess treatment impact, and chest X-rays will also be taken. Blood samples will be collected, and the overall health status of participants will be monitored according to the Ministry of Health protocol. The study uses a randomized design with single masking, and the total participation period includes the 5-day treatment and follow-up assessments.
CONDITIONS
Brief Title
The Course of Acute Respiratory Failure in Geriatric Patients With Hip Fracture Using Different Modes of a Vibroacoustic Device for the Lungs
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Respiratory failure
- Hip fracture
- Injury Severity Score no higher than 8 points
- Age between 60 and 85 years
You will not qualify if you...
- Any contraindications for use of the device
- Terminal condition of the patient
- Shock
- Paradoxical pathological breathing
- Hypertensive crisis
- Severe hypocoagulation with risk of hematoma or bleeding in the treatment area
- Severe hypercoagulation with risk of thrombus or embolus migration in the treatment area
- Acute cerebrovascular accident within the first 1-3 days
- Brain edema
- Multiple purulent or burn wounds in the treatment area
- Unstable rib fractures
- Pneumomediastinum and/or subcutaneous emphysema of the chest
- Osteomyelitis of ribs or thoracic spine
- Spinal fracture without orthopedic fixation
- Chest or abdominal trauma with bleeding
- Injury Severity Score greater than 8 points
- Concomitant diseases in decompensation stage
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Duration of hospital stay with hip fracture and respiratory failure
Participants undergo vibroacoustic pulmonary therapy using the Vibrolung device in either the "Pneumonia" or "Prevention" mode.
Multiple sessions of approximately 5 minutes each as per assigned treatment mode
Trial Site Locations
Total: 1 location
1
Astana medical university
Astana, Kazakhstan, 010000
Actively Recruiting
Research Team
A
Assema Bekniyazova
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
BASIC_SCIENCE
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here